118 related articles for article (PubMed ID: 20394861)
1. Response to "benefit of radiation boost after whole-breast radiotherapy" (Int J Radiat Oncol Biol Phys 2009;75:1029-1034).
Voogd AC; van der Sangen MJ
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):316; author reply 316. PubMed ID: 20394861
[No Abstract] [Full Text] [Related]
2. Benefit of radiation boost after whole-breast radiotherapy.
Livi L; Borghesi S; Saieva C; Fambrini M; Iannalfi A; Greto D; Paiar F; Scoccianti S; Simontacchi G; Bianchi S; Cataliotti L; Biti G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1029-34. PubMed ID: 19395193
[TBL] [Abstract][Full Text] [Related]
3. In regard to Wahl et al. (Int J Radiat Oncol Biol Phys 2008;70:477-484).
Hannoun-Levi JM; Raoust I
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1603-4; author reply 1604. PubMed ID: 18640511
[No Abstract] [Full Text] [Related]
4. Breast conservative surgery with close or positive margins: in regard to Guinot et Al. (Int J Radiat Oncol Biol Phys 2007;68:1381-1387).
Sanz J; de Dios NR; Arnalot PF; López MA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):962-3; author reply 963. PubMed ID: 18262110
[No Abstract] [Full Text] [Related]
5. Impact of the radiation boost on outcomes after breast-conserving surgery and radiation: in regard to Murphy C, et al. (Int J Radiat Oncol Biol Phys in press).
Lima CG; Cordova AL; Balloni H; Lima CG; Thiago EL; Cordova AL
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):314. PubMed ID: 21481726
[No Abstract] [Full Text] [Related]
6. Response to "Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy." (Int J Radiat Oncol Biol Phys 2011;80:398-402).
Tsoutsou PG; Jeanneret Sozzi W; Ozsahin M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):519; author reply 519-20. PubMed ID: 22244276
[No Abstract] [Full Text] [Related]
7. In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).
Munshi A; Jalali R; Budrukar A
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):632; author reply 632-3. PubMed ID: 16690446
[No Abstract] [Full Text] [Related]
8. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery: in regards to Toledano et al. (Int J Radiat Oncol Biol Phys 2006;65:324-332).
Munshi A; Jalali R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):314; author reply 314-5. PubMed ID: 16904531
[No Abstract] [Full Text] [Related]
9. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy?
Prager D; Grundfest-Broniatowski S; Lerner HJ; Margolese RG; Dimitrov N; Silverman P
Semin Oncol; 1995 Aug; 22(4):xiii, xix-xx, xxvi-xxvii passim. PubMed ID: 7638627
[No Abstract] [Full Text] [Related]
11. [Current trends in the treatment of primary breast cancer].
Letiagin VP
Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
[No Abstract] [Full Text] [Related]
12. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
[TBL] [Abstract][Full Text] [Related]
13. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
Garces YI; Miller RC
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
[No Abstract] [Full Text] [Related]
14. [Effectiveness of adjuvant systemic therapy in organ preserving treatment of pT1-2N0M0 breast cancer].
Semiglazov VF; Kanaev SV; Bugrova IL; Vlasov AN
Vopr Onkol; 1999; 45(5):516-9. PubMed ID: 10629708
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of stage I-IIA breast cancer of medial-central localization].
Datsenko VS
Khirurgiia (Mosk); 1998; (11):35-7. PubMed ID: 9864983
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy in breast cancer.
Robert NJ
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
[TBL] [Abstract][Full Text] [Related]
17. A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer.
Arcangeli G; Pinnarò P; Rambone R; Giannarelli D; Benassi M
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):161-7. PubMed ID: 16226397
[TBL] [Abstract][Full Text] [Related]
18. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.
Antonini N; Jones H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Jager J; Hoogenraad W; Collette L; Pierart M; Hart G; Bartelink H
Radiother Oncol; 2007 Mar; 82(3):265-71. PubMed ID: 17126434
[TBL] [Abstract][Full Text] [Related]
19. In regard to Vicini et al. (Int J Radiat Oncol Biol Phys 2007;68:341-346).
Rodriguez de Dios N; Bassols ML; Latiesas XS; López MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1336-7. PubMed ID: 17967329
[No Abstract] [Full Text] [Related]
20. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
Vordermark D; Kölbl O
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):296-7; author reply 297. PubMed ID: 15850943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
